NY-HOTWIRE
2.2.2021 16:05:12 CET | Business Wire | Press release
Hotwire, the global technology communications consultancy, today announced it will commit up to $1 million in services to support tech and tech-enabled organizations led by or supporting minority communities. The Program is part of Hotwire’s Diversity, Equity, and Inclusion (DEI) strategy to amplify people and organizations creating meaningful and sustainable change in the world through technology innovation.
“We started the Hotwire Ignite Possibility Program to direct more of our resources to organizations that align with our diversity, equity, and inclusion goals,” said Barbara Bates, CEO. “We have been providing pro bono services to impactful organizations for years, but now, with the Hotwire Ignite Possibility Program, we can do more to advance social justice through our services.”
Any tech or tech-enabled organization—for-profit, non-profit, education, or government—that is either minority-led or providing a product or service benefitting minority communities in a country with a Hotwire office may qualify. Hotwire will work with local community tech leaders addressing inequalities in business and tech to reach organizations who can benefit from brand, marketing or PR pro bono services.
“Having recently had the honor of being named Global Technology Agency of the Year by PRovoke Media, we have a responsibility to lead by example and address the inequality of resources for tech organizations,” noted Bates. “The Hotwire Ignite Possibility Program is one way we can do that,” she added.
Hotwire’s DEI strategy launched in early 2020 and includes specific commitments and a phased rollout schedule. Starting with internal operations and employee engagement initiatives aimed at building a diverse employee population and creating an inclusive environment where differences are celebrated, the firm is now extending the focus externally with the Hotwire Ignite Possibility Program. Hotwire has also signed the Diversity Action Alliance commitment, joining other PR and communications leaders to accelerate progress in the achievement of meaningful and tangible results in diversity, equity and inclusion across our profession.
By earmarking up to $1 million in services to organizations that meet the selection criteria, Hotwire is increasing the amount of support they provide to tech organizations in need of brand, marketing, and public relations expertise that otherwise may not have had access to these resources. The end goal of the Program is to help more tech and tech-enabled organizations that are advancing diversity, equity, and inclusion through technology innovation scale and succeed in today’s competitive tech sector.
Applications are now open for organizations in the US , UK and Germany until March 15th , 2021. An announcement of selected organizations in those countries will be made in April 2021. Applications for Australia open later in 2021 and Hotwire may reopen applications in other regions throughout the year. Follow us on Twitter and LinkedIn to get updates. Have questions? Email HIPP@hotwireglobal.com
About Hotwire
Hotwire is the global technology communications consultancy. Founded in 2000, we operate a worldwide network of wholly owned offices and partners serving a range of clients from scale ups to established multi-nationals. We unleash the possibilities of innovative technology through integrated communications that ignite curiosity, spark action and fuel success. We do this using our proprietary methodology which is underpinned by robust insight and strategy, purposeful creative, integrated planning and a core emphasis on measurement and evaluation.
About Enero
The Enero Group limited, a boutique network of marketing and communication businesses, is listed on the Australian Securities Exchange (asx:EGG). The group includes advertising agency BMF, PR agencies CPR, Frank and Hotwire, digital agency Orchard, research consultancies The Leading Edge and The Digital Edge, and programmatic marketing specialist OB media. For more information, please visit www.enero.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005795/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
